11.01.18
PMI BioPharma Solutions, a specialty CDMO formed in January of 2018. Dr. Sunseri is an accomplished pharmaceutical industry executive and previously served as senior vice president, Pharmaceutical Development and chief business development officer at PMI BioPharma Solutions.
Prior to PMI Bio, David spent almost four years at Berg, LLC, in positions of increasing responsibility leading all aspects of CMC. Most recently, he served as vice president, Product Development, responsible for clinical trial manufacturing, engineering operations, supply chain, and formulations. He also spent approximately 10 years with Schering-Plough and Merck in small molecule inhalation and parenteral development and commercial manufacturing of inhalation and medical device products.
"Dave is a leader who has demonstrated a tireless focus on leadership, execution and delivering results. His vision along with his teambuilding skills have facilitated the launch of PMI Bio while also serving to make him the ideal leader to rapidly grow the business in both the short and long term," said Mitch Gray, managing partner. Dr. Sunseri commented, "I look forward to this opportunity to grow PMI BioPharma into a premier service provider to the pharma and biopharma community."
PMI BioPharma Solutions offers manufacturing and aseptic fill & finish services along with contract research and drug discovery services for clients in the pharmaceutical and biotechnology industries that seek to outsource individual projects, as well as engage in discovery campaigns.
David Sunseri, Ph.D. has been appointed chief executive officer ofPrior to PMI Bio, David spent almost four years at Berg, LLC, in positions of increasing responsibility leading all aspects of CMC. Most recently, he served as vice president, Product Development, responsible for clinical trial manufacturing, engineering operations, supply chain, and formulations. He also spent approximately 10 years with Schering-Plough and Merck in small molecule inhalation and parenteral development and commercial manufacturing of inhalation and medical device products.
"Dave is a leader who has demonstrated a tireless focus on leadership, execution and delivering results. His vision along with his teambuilding skills have facilitated the launch of PMI Bio while also serving to make him the ideal leader to rapidly grow the business in both the short and long term," said Mitch Gray, managing partner. Dr. Sunseri commented, "I look forward to this opportunity to grow PMI BioPharma into a premier service provider to the pharma and biopharma community."
PMI BioPharma Solutions offers manufacturing and aseptic fill & finish services along with contract research and drug discovery services for clients in the pharmaceutical and biotechnology industries that seek to outsource individual projects, as well as engage in discovery campaigns.